This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
MD‐7246, a Delayed‐Release Formulation of Linaclotide Targeting Visceral Pain Associated With IBS‐D, Does Not Impact Bowel Frequency or Stool Consistency in Healthy Volunteers: Results From Phase I Trial: 497. (October 2019)
Record Type:
Journal Article
Title:
MD‐7246, a Delayed‐Release Formulation of Linaclotide Targeting Visceral Pain Associated With IBS‐D, Does Not Impact Bowel Frequency or Stool Consistency in Healthy Volunteers: Results From Phase I Trial: 497. (October 2019)
Main Title:
MD‐7246, a Delayed‐Release Formulation of Linaclotide Targeting Visceral Pain Associated With IBS‐D, Does Not Impact Bowel Frequency or Stool Consistency in Healthy Volunteers: Results From Phase I Trial